Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

NCT02839915 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
56
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Southwest Autism Research & Resource Center

Collaborators